213 related articles for article (PubMed ID: 11905737)
21. [Association of congenital chromosome abnormalities and malignant diseases].
Erzsébet B; Andrea N; Róbert S; Eva O
Orv Hetil; 1996 Feb; 137(5):227-31. PubMed ID: 8882440
[TBL] [Abstract][Full Text] [Related]
22. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
Langebrake C; Creutzig U; Reinhardt D
Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
[TBL] [Abstract][Full Text] [Related]
23. Prognosis of Down's syndrome with acute leukaemia.
Levitt GA; Stiller CA; Chessells JM
Arch Dis Child; 1990 Feb; 65(2):212-6. PubMed ID: 2138446
[TBL] [Abstract][Full Text] [Related]
24. Concomitant aberrant overexpression of RUNX1 and NCAM in regenerating bone marrow of myeloid leukemia of Down's syndrome.
Langebrake C; Klusmann JH; Wortmann K; Kolar M; Puhlmann U; Reinhardt D
Haematologica; 2006 Nov; 91(11):1473-80. PubMed ID: 17043020
[TBL] [Abstract][Full Text] [Related]
25. Down's syndrome and acute leukaemia.
Lancet; 1972 Dec; 2(7788):1187. PubMed ID: 4117604
[No Abstract] [Full Text] [Related]
26. Unrelated donor bone marrow transplantation for acute leukemia in patients with Down's syndrome.
Pawlowska AB; Davies SM; Orchard PJ; Wagner JE; Ramsay NK
Bone Marrow Transplant; 1996 Aug; 18(2):453-5. PubMed ID: 8864463
[TBL] [Abstract][Full Text] [Related]
27. Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891.
Gamis AS; Woods WG; Alonzo TA; Buxton A; Lange B; Barnard DR; Gold S; Smith FO;
J Clin Oncol; 2003 Sep; 21(18):3415-22. PubMed ID: 12885836
[TBL] [Abstract][Full Text] [Related]
28. Mortality and cancer incidence among individuals with Down syndrome.
Hill DA; Gridley G; Cnattingius S; Mellemkjaer L; Linet M; Adami HO; Olsen JH; Nyren O; Fraumeni JF
Arch Intern Med; 2003 Mar; 163(6):705-11. PubMed ID: 12639204
[TBL] [Abstract][Full Text] [Related]
29. Association between presenilin-1 -48C/T polymorphism and Down's syndrome.
Lucarelli P; Piciullo A; Palmarino M; Verdecchia M; Saccucci P; Arpino C; Curatolo P
Neurosci Lett; 2004 Aug; 367(1):88-91. PubMed ID: 15308304
[TBL] [Abstract][Full Text] [Related]
30. Neoplastic disorders of hematopoiesis in children with Down's syndrome--a single institution experience in Taiwan.
Chang HH; Lu MY; Jou ST; Lin KH; Tien HF; Wu ET; Lin DT
J Formos Med Assoc; 2005 May; 104(5):333-40. PubMed ID: 15959600
[TBL] [Abstract][Full Text] [Related]
31. MTHFR 677C-->T and 1298A-->C polymorphisms in children with Down syndrome and acute myeloid leukemia in Brazil.
Amorim MR; Zanrosso CW; Magalhães IQ; Pereira SC; Figueiredo A; Emerenciano M; Pinheiro VR; d'Andréa ML; Orioli IM; Koifman S; Pombo-de-Oliveira MS
Pediatr Hematol Oncol; 2008 Dec; 25(8):744-50. PubMed ID: 19065440
[TBL] [Abstract][Full Text] [Related]
32. Dermatological manifestations of Down's syndrome.
Madan V; Williams J; Lear JT
Clin Exp Dermatol; 2006 Sep; 31(5):623-9. PubMed ID: 16901300
[TBL] [Abstract][Full Text] [Related]
33. Vitamin supplement use among children with Down's syndrome and risk of leukaemia: a Children's Oncology Group (COG) study.
Blair CK; Roesler M; Xie Y; Gamis AS; Olshan AF; Heerema NA; Robison LL; Ross JA;
Paediatr Perinat Epidemiol; 2008 May; 22(3):288-95. PubMed ID: 18426524
[TBL] [Abstract][Full Text] [Related]
34. [Constitutional chromosome abnormalities and acute leukemia].
Turc-Carel C; Mugneret F; Sidaner I
Pathol Biol (Paris); 1982 Nov; 30(9):792-7. PubMed ID: 6218469
[TBL] [Abstract][Full Text] [Related]
35. Cytogenetic and molecular study of 32 Down syndrome families: potential leukaemia predisposing role of the most proximal segment of chromosome 21q.
Cavani S; Perfumo C; Argusti A; Pierluigi M; Perroni L; Schmiegelow K; Petersen MB; Cotter FE; Strigini P; Dagna-Bricarelli F; Nizetić D
Br J Haematol; 1998 Oct; 103(1):213-6. PubMed ID: 9792310
[TBL] [Abstract][Full Text] [Related]
36. Down syndrome and leukemia, an update.
Drabkin HA; Erickson P
Prog Clin Biol Res; 1995; 393():169-76. PubMed ID: 8545449
[TBL] [Abstract][Full Text] [Related]
37. Down's syndrome as a model disease.
Scoggin CH; Patterson D
Arch Intern Med; 1982 Mar; 142(3):462-4. PubMed ID: 6461305
[TBL] [Abstract][Full Text] [Related]
38. Clinical manifestations of hematologic and oncologic disorders in patients with Down syndrome.
Dixon N; Kishnani PS; Zimmerman S
Am J Med Genet C Semin Med Genet; 2006 Aug; 142C(3):149-57. PubMed ID: 17048354
[TBL] [Abstract][Full Text] [Related]
39. Leukaemia and transient leukaemia in Down syndrome.
Iselius L; Jacobs P; Morton N
Hum Genet; 1990 Oct; 85(5):477-85. PubMed ID: 2146208
[TBL] [Abstract][Full Text] [Related]
40. Deletions of chromosome 21 restricted to the leukemic cells of children with Down syndrome and leukemia.
Kempski HM; Chessells JM; Reeves BR
Leukemia; 1997 Nov; 11(11):1973-7. PubMed ID: 9369434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
